miR-181a modulates acute myeloid leukemia susceptibility to natural killer cells.
Nanbakhsh A, Visentin G, Olive D, Janji B, Mussard E, Dessen P, Meurice G, Zhang Y, Louache F, Bourhis JH, Chouaib S.
Nanbakhsh A, et al. Among authors: visentin g.
Oncoimmunology. 2015 Oct 16;4(12):e996475. doi: 10.1080/2162402X.2014.996475. eCollection 2015 Dec.
Oncoimmunology. 2015.
PMID: 26587335
Free PMC article.